The subcutaneous shot carries the same indications as intravenous amivantamab but cuts administration time to minutes.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-oks-subcutaneous-amivantamab-egfr-mutated-nsclc-2025a1000zrv?src=rss
Author :
Publish date : 2025-12-19 05:43:00
Copyright for syndicated content belongs to the linked Source.